Sarah Nicole Forrester, Ann Moormann awarded $2 million NCI SeroNet grant
GlaxoSmithKline's vaccines group aims for a first as it kicks off PhIII RSV studies
SARS-CoV-2 Uses a Second Receptor, Neuropilin-1, to Infect Human Cells
New system based on photonic sensors could enable early detection of SARS-CoV-2
Is reaching zero COVID-19 possible?
Goldman Sachs: 2 Stocks That Could Climb Over 90%
Sanofi preps trials of second COVID-19 shot, as Russia approves another
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
France Reports Record 30,000 Cases In 24 Hours As Europe Tops US Tally Yet Again: Live Updates
What developing countries can teach us about how to respond to a pandemic
Regeneron Scores FDA Nod For Ebola Treatment
Could an existing vaccine make COVID-19 less deadly? Mexico City study provides support
Army researchers collaborate on universal antibody test for COVID-19
Obesity implies risk of COVID-19 regardless of age, sex, ethnicity and health condition
Immune failure can cause serious COVID-19
NIH study aims to identify promising COVID-19 treatments for larger clinical trials
News briefing: Regeneron/Sanofi post positive PhIII Dupixent data in pediatric asthma; Vineti scores $33M Series C extension
Existing medicines could help improve immune function in vulnerable older adults
Dynavax Surges 7% In Pre-Market On Taiwan Covid-19 Vaccine Subsidy
Sorrento Adds Stem Cell Treatment To Covid-19 Pipeline; Shares Rise
Takeda group begins manufacturing Covid-19 plasma treatment ahead of approval
Sonoco To Sell Its Contract Packaging Operations For $120M
Covid-19 antibodies last at least three months; so do symptoms for many
Abbott wins U.S. emergency use authorization for new Covid-19 antibody test
3 COVID-19 Antibody Stocks That Are Leading the Race
Spotlight on COVID-19 antibody therapies after Trump’s recovery
Eli Lilly In Gates Foundation Supply Deal For Covid-19 Antibodies
Pfizer, BioNTech Initiate Rolling Canada Submission For Covid-19 Vaccine
AstraZeneca Inks $486M US Support For Covid-19 Antibody Cocktail
Global Trial Launches to Test Remdesivir with hIVIG in Covid-19